Inventor · disambiguated record
Robert A. Macleod
Also filed as: MACLEOD ROBERT · MACLEOD ROBERT A
21 granted patents·11 pending applications·180 citations·filing 1998–2024
94Inventor score
Files withIONIS PHARMACEUTICALS INC17ISIS PHARMACEUTICALS INC4BHATTACHARJEE GOURAB2METHYLGENE INC2MONIA BRETT P2
Top patents by PatentIndex Score
32 records- 0196US9765338B2Modulation of dystrophia myotonica-protein kinase (DMPK) expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·67 cites·24 claims
- 0293US9546368B2Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expressionIONIS PHARMACEUTICALS INC·Filed 2012·Granted Jan 17, 2017·16 cites·20 claims
- 0393US8816056B2Modulation of signal transducer and activator of transcription 3 (STAT3)expressionSWAYZE ERIC E·Filed 2012·Granted Aug 26, 2014·17 cites·17 claims
- 0492US12157890B2Modulators of MALAT1 expressionIONIS PHARMACEUTICALS INC·Filed 2022·Granted Dec 3, 2024·1 cites·13 claims
- 0586US9359608B2Modulation of signal transducer and activator of transcription 3 (STAT3) expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Jun 7, 2016·5 cites·25 claims
- 0684US2025136986A1Modulators of malat1 expressionIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0783US11547718B2Modulators of FOXP3 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Jan 10, 2023·1 cites·4 claims
- 0883US9315811B2Methods for modulating kallikrein (KLKB1) expressionBHATTACHARJEE GOURAB·Filed 2012·Granted Apr 19, 2016·8 cites·22 claims
- 0982US11241451B2Modulators of IRF4 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Feb 8, 2022·1 cites·22 claims
- 1080US9175291B2Modulation of androgen receptor expressionISIS PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·4 cites·20 claims
- 1175US9322021B2Methods for modulating kallikrein (KLKB1) expressionREVENKO ALEXEY·Filed 2012·Granted Apr 26, 2016·7 cites·30 claims
- 1273US12042510B2Modulators of IRF4 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Jul 23, 2024·0 cites·17 claims
- 1372US9150864B2Methods for modulating factor 12 expressionMONIA BRETT P·Filed 2011·Granted Oct 6, 2015·1 cites·21 claims
- 1472US6066625AOptimized antisense oligonucleotides complementary to DNA methyltransferase sequencesMETHYLGENE INC·Filed 1998·Granted May 23, 2000·25 cites·5 claims
- 1572US2023201243A1Modulators of foxp3 expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1671US11279932B2Modulators of MALAT1 expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Mar 22, 2022·0 cites·8 claims
- 1770US2020385716A1Modulation of signal transducer and activator of transcription 3 (stat3) expressionSWAYZE ERIC E·Filed 2019·Application pending·0 cites
- 1869USRE48461EModulation of androgen receptor expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·0 cites·50 claims
- 1968US2020362353A1Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) ExpressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2067US9187749B2Methods for modulating factor 12 expressionBHATTACHARJEE GOURAB·Filed 2012·Granted Nov 17, 2015·1 cites·22 claims
- 2165US11214803B2Modulators of YAP1 expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Jan 4, 2022·0 cites·23 claims
- 2265US6953783B1Modulation of gene expression by combination therapyMETHYLGENE INC·Filed 1999·Granted Oct 11, 2005·26 cites·4 claims
- 2363US2022315927A1Modulators of yap1 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2462US2018163209A1Modulation of dystrophia myotonica-protein kinase (dmpk) expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2562US2016304877A1Compounds and methods for modulation of dystrophia myotonica-protein kinase (dmpk) expressionIONIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2661US11365416B2Modulators of EZH2 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Jun 21, 2022·0 cites·18 claims
- 2759US10479993B2Modulation of signal transducer and activator of transcription 3 (STAT3) expressionISIS PHARMACEUTICALS INC·Filed 2016·Granted Nov 19, 2019·0 cites·2 claims
- 2856US2013237585A1Modulation of dystrophia myotonica-protein kinase (dmpk) expressionBENNETT C FRANK·Filed 2011·Application pending·0 cites
- 2952US9567588B2Modulation of androgen receptor expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·0 cites·30 claims
- 3048US2003096777A1Modulation of gene expression by combination therapyFiled 2002·Application pending·0 cites
- 3137US2018273577A1Modulators of kras expressionIONIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3235US2012083522A1Modulation of inflammatory responses by factor xiMONIA BRETT P·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →